| | | | | |
PLMK Plum Acquisition Corp. IV Class A Ordinary Shares | €9,1632 | -0,05% | €221,93M | €43,63K | |
DMAA Drugs Made In America Acquisition Corp. Ordinary Shares | €9,1373 | +0,00% | €221,82M | €6,37K | |
ERC Allspring Multi-Sector Income Fund | €7,7508 | -0,77% | €221,78M | €49,22K | |
GLO Clough Global Opportunities Fund | €5,2232 | +0,50% | €221,71M | €103,53K | |
NTWO Newbury Street II Acquisition Corp Class A Ordinary Shares | €9,1546 | -0,09% | €221,60M | €106,78 | |
TRGS TRG Latin America Acquisitions Corp. Class A Ordinary Shares | €8,5078 | -0,01% | €221,12M | €14,05K | |
CPZ Calamos Long/Short Equity & Dynamic Income Trust Common Stock | €10,9717 | -0,86% | €220,63M | €57,53K | |
| €3,3759 | +1,03% | €220,37M | €154,95K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,3349 | -7,19% | €220,18M | €2,44M | |
PNNT Pennant Investment Corp | €3,4448 | +2,83% | €219,87M | €631,44K | |
VNME Vendome Acquisition Corporation I Class A Ordinary Shares | €8,7842 | -0,10% | €219,60M | €180,85 | |
NUW Nuveen AMT-Free Municipal Value Fund | €12,0568 | +0,29% | €219,52M | €63,35K | |
| €34,0475 | +3,71% | €219,52M | €8,05K | |
DSP Viant Technology Inc. Class A Common Stock | €10,9545 | +5,12% | €219,32M | €181,51K | |
| €25,1169 | +2,12% | €219,22M | €65,43K | |
